English
Regional settings| Spread | 0.09 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 29.25 |
| Open | 29.01 |
| 1-Year Change | -9.68% |
| Day's Range | 29.01 - 29.76 |
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company provides a therapy portfolio through its network of approximately 97 full-service pharmacies and 57 stand-alone ambulatory infusion suites. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. It administers a range of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, women’s health and others. It also offers nursing platform that include specialty nursing resources to healthcare providers.
BRIEF: For the fiscal year ended 31 December 2021, Option Care Health Inc revenues increased 13% to $3.44B. Net income totaled $139.9M vs. loss of $8.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Total other expense decrease of 38% to $67M (expense), Other, net - Balancing value decrease of 53% to $10.8M (expense).
Common Stock $.0001 Par, 3/11, 125M auth., 57,063,496 issd., less 2,642,398 shs. in Treas. @ $10.6M. Insiders & strategic holders own 2.32%. IPO: 8/96, 4M shares @ $13 by PaineWebber Inc. 03/05, Co. acq. Chronimed Inc. @ 1.12 sh of BIOS (14,363,933 shs issd.) & also name changed from MIM Corporation following the merger.
